Christine Antalik - British Amer Chief Financial Officer
BTI Stock | CAD 0.01 1.24 99.60% |
CFO
Ms. Christine Antalik is Chief Financial Officer of the Company. Antalik is the managing member of Founders Bridge Advisors, LLC, a business advisory firm located in Connecticut, and has served as chief financial officer of Aeromics, Inc. since October 2016. Previously, Antalik served as chief financial officer of SurgiQuest, Inc. where she led the 265 million acquisition of SurgiQuest, Inc. by CONMED Corporation after filing the company public S1 statement. Antalik closed a 108 million initial public offering as the vice president of finance and controller at HigherOne, Inc., a financial technology company. Prior to HigherOne, Antalik served as controller for Tangoe, Inc., a software service company. As chief financial officer and treasurer of Hematech, LLC, Antalik formed a joint venture with a key services provider to mitigate business risk and ultimately steered the company to a successful exit, being acquired by Kirin Brewery Company, Limited. Antalik also previously served as controller and senior manager of litigation support and business valuation for Centerprise Advisors, Inc., a national consulting and accounting advisory firm, where she provided expert witness reports in economic damages cases, business valuations and forensic accounting services. Antalik earned her bachelor of science degree in business administration from Western New England College, Springfield, Mass. since 2019.
Tenure | 5 years |
Address | 157 Church Street, New Haven, CT, United States, 06510 |
Phone | 203 533 7082 |
Web | https://www.bioasis.us |
British Amer Management Efficiency
The company has return on total asset (ROA) of (0.8058) % which means that it has lost $0.8058 on every $100 spent on assets. This is way below average. British Amer's management efficiency ratios could be used to measure how well British Amer manages its routine affairs as well as how well it operates its assets and liabilities. At this time, British Amer's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 1.54 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (6.59). At this time, British Amer's Non Current Assets Total are fairly stable compared to the past year. Intangible Assets is likely to climb to about 452.7 K in 2024, whereas Total Current Assets are likely to drop slightly above 711.9 K in 2024.Similar Executives
Found 4 records | CFO Age | ||
Rod Bolger | Royal Bank of | N/A | |
Riaz Ahmed | Toronto Dominion Bank | N/A | |
Kelvin CFA | Toronto Dominion Bank | N/A | |
Kelvin Tran | Toronto Dominion Bank | N/A |
Management Performance
Return On Asset | -0.81 |
biOasis Technologies Leadership Team
Elected by the shareholders, the British Amer's board of directors comprises two types of representatives: British Amer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of British. The board's role is to monitor British Amer's management team and ensure that shareholders' interests are well served. British Amer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, British Amer's outside directors are responsible for providing unbiased perspectives on the board's policies.
David Wurzer, Independent Director | ||
Doug Williams, Executive Vice-President Chief Business Officer | ||
David Jenkins, Chief Officer | ||
Mario Saltarelli, Non-Executive Director | ||
Graeme Dick, Director Relations | ||
Doug MBA, Exec Officer | ||
Christine Antalik, Chief Financial Officer | ||
John Curran, Independent Director | ||
Kim Elton, Director Marketing | ||
Caroline Dircks, Chief Operating Officer | ||
Deborah Rathjen, Executive Chairman of the Board, President, Chief Executive Officer | ||
Aaron Elton, Director Marketing | ||
Mei Tian, VP Research | ||
Dave Jenkins, Chief Officer | ||
B FTSE, CEO Chairman |
British Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is British Amer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -0.81 | ||||
Operating Margin | (4.69) % | ||||
Current Valuation | 2.45 M | ||||
Shares Outstanding | 79.41 M | ||||
Shares Owned By Insiders | 2.05 % | ||||
Number Of Shares Shorted | 105.04 K | ||||
Price To Earning | 25.91 X | ||||
Price To Book | 54.04 X | ||||
Price To Sales | 1.47 X | ||||
Revenue | 269.38 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for British Stock Analysis
When running British Amer's price analysis, check to measure British Amer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy British Amer is operating at the current time. Most of British Amer's value examination focuses on studying past and present price action to predict the probability of British Amer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move British Amer's price. Additionally, you may evaluate how the addition of British Amer to your portfolios can decrease your overall portfolio volatility.